Autologous blood products: when, where, and how?

AA Tovar, AL Sabater - Current Ophthalmology Reports, 2021 - Springer
Abstract Purpose of Review In this article, we review the latest clinical outcomes of the
treatment of ocular surface diseases with autologous blood products. Recent Findings …

Real life data on efficacy and safety of topical NGF eye drops (Cenegermin)

SB Zwingelberg, BO Bachmann… - Klinische Monatsblätter …, 2020 - thieme-connect.com
Hintergrund Augentropfen mit dem Wirkstoff Cenegermin, eine rekombinante Form des
menschlichen Nerve Growth Factor (NGF), wurden 2015 als Orphan-Arzneimittel zur …

How does ocular graft‐versus‐host disease fit under the dry eye umbrella? A review

NB Kantor, A Tovar, T Wang… - Clinical & experimental …, 2024 - Wiley Online Library
Graft‐versus‐host disease (GVHD) is a systemic disease that can affect multiple organs as a
consequence of an allogeneic haematopoietic stem cell transplant. One organ system that is …

Therapeutic efficacy and safety of intense pulsed light for meibomian gland dysfunction in patients with chronic ocular graft-versus-host disease

X Song, Z Chen, J Li, S Wu, L Liang - Ocular Immunology and …, 2023 - Taylor & Francis
Purpose To evaluate the efficacy and safety of intense pulsed light combined with
meibomian gland expression (IPL-MGX) for treating meibomian gland dysfunction (MGD) …

[HTML][HTML] Detection of systemic immunosuppressants in autologous serum eye drops (ASED) in patients with severe chronic ocular graft versus host disease

V Tahmaz, MHJ Wiesen, U Gehlsen… - Graefe's Archive for …, 2021 - Springer
Purpose Chronic graft versus host disease is a major consequence after allogeneic stem
cell transplantation (allo-SCT) and has great impact on patients' morbidity and mortality …

[HTML][HTML] Aberrant HLA-DR expression in the conjunctival epithelium after autologous serum treatment in patients with graft-versus-host disease or Sjögren's syndrome

K Jirsova, P Seidler Stangova, M Palos, G Mahelkova… - PloS one, 2020 - journals.plos.org
The aim of this study was to determine the effect of autologous serum (AS) eye drops on the
density of human leucocyte antigen (HLA)-DR-positive epithelial cells and Langerhans cells …

Ocular graft versus host disease: corneal complications

H Westekemper, SL Scholz, H Thomasen… - Der …, 2017 - Springer
Hintergrund Die okuläre GvHD („graft versus host disease “; Transplantat-gegen-Wirt-
Reaktion) nach allogener Blutstammzelltransplantation beinhaltet immunologisch …

[HTML][HTML] Autologous serum tears improve corneal nerve density and sensitivity in patients with ocular graft-versus-host disease-associated dry eye disease

JT Carreno-Galeano, LK Johns, R Dana, J Yin - The ocular surface, 2023 - ncbi.nlm.nih.gov
Graft-versus-host disease (GVHD) is a multi-organ complication from allogeneic bone
marrow or hematopoietic stem cell transplantation used to treat malignant and benign …

Mapping research trends of chronic ocular graft-versus-host disease from 2009 to 2020: a bibliometric analysis

J Xu, F Zhao, J Fang, M Shi, J Pan, W Sun… - International …, 2022 - Springer
Purpose To evaluate the global scientific output of research on ocular chronic Graft versus
host disease (cGVHD) and explore the current status and trends in this field over the past …

Semifluorinated alkane eye drops in chronic ocular graft-versus-host disease: a prospective, multicenter, noninterventional study

P Eberwein, S Krösser, P Steven - Ophthalmic Research, 2020 - karger.com
Purpose: Ocular graft-versus-host disease (oGvHD) following allogeneic hematopoietic stem
cell transplantation develops as severe dry eye disease (DED) and is initially treated with …